Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Villagra

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Molecular Immunology|August 27, 2014
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and functionEva Sahakian, John J Powers, Jie Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2014
A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCsFengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Journal of Medicinal Chemistry|May 29, 2026
Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint BlockadeNithya Gajendran, Manasa Suresh, Sebastian J Marquez R, et al.
Journal of Medicinal Chemistry|August 27, 2025
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group ModificationsOlasunkanmi O Olaoye, Fettah Erdogan, Maria Gracia-Hernandez, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Blood|May 28, 2017
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine modelDavid M Woods, Karrune V Woan, Fengdong Cheng, et al.
Journal of Leukocyte Biology|May 28, 2017
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biologyEva Sahakian, Jie Chen, John J Powers, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanomaSatish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, et al.
Cancer Discovery|December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotypeKim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Molecular Immunology|August 27, 2014
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and functionEva Sahakian, John J Powers, Jie Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2014
A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCsFengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Journal of Medicinal Chemistry|May 29, 2026
Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint BlockadeNithya Gajendran, Manasa Suresh, Sebastian J Marquez R, et al.
Journal of Medicinal Chemistry|August 27, 2025
Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group ModificationsOlasunkanmi O Olaoye, Fettah Erdogan, Maria Gracia-Hernandez, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Blood|May 28, 2017
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine modelDavid M Woods, Karrune V Woan, Fengdong Cheng, et al.
Journal of Leukocyte Biology|May 28, 2017
Essential role for histone deacetylase 11 (HDAC11) in neutrophil biologyEva Sahakian, Jie Chen, John J Powers, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanomaSatish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, et al.
Cancer Discovery|December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotypeKim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Pageof 6